AIXC

AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company headquartered in Carlsbad, California, dedicated to advancing innovative therapies for adult and pediatric cancer patients. Leveraging cutting-edge research and development capabilities, the company aims to transform the landscape of cancer treatment through its proprietary formulations and therapeutic modalities. With a robust pipeline of candidates in various stages of clinical trials, AIxCrypto is positioned to address significant unmet medical needs in oncology, aiming to enhance patient outcomes and quality of life.